Mike Dziubina
Well-Known Member
I know there are some doc's on here so just looking for some help if possible. I have a presentation due Wednesday for pharmacology. I was assigned to do this NME for 2009 called Savella (Milnacipran), it is a SNRI used to treat depression and fibromyalgia, for my report it is geared more towards FM. I understand it is a re uptake inhibitor of Norepinephrine and serotonin but what i am confused about is how this in turn helps deal with the "pain signal" with FM. by blocking the receptor on the presynaptic terminal, you are increasing synaptic cleft levels of Serotonin and NorE. how does this help with FM? is it because there are MAO and COMT in the cleft which breakdown the NTMs and limit presynaptic levels of the NTMs??? thank you guys i appreciate it.